Bitcoin

The convergence of AI and gene editing accelerates the need for decentralized infrastructure to manage IP, data provenance, and ethical oversight. This aligns with the growing DeSci (Decentralized Science) movement, which leverages blockchain for research funding, data sharing, and tokenized incentives. Over time, such breakthroughs could drive demand for decentralized compute networks (e.g., Akash, Render) and storage (e.g., Filecoin, Arweave).

Researchers used AI to design functional CRISPR enzymes not found in nature, published in Nature on 16 July 2026.

AI-Designed CRISPR Enzymes Could Deepen Altcoin Liquidity Drought

AI-designed CRISPR enzymes will accelerate a capital rotation from crypto to biotech, deepening the current liquidity drought in altcoins.

South Korea's equity and crypto markets are closely linked through a retail investor base that often trades both. A stock rebound may signal a broader risk-on shift, contrasting with the current global extreme fear (F&G=8). While not a direct crypto catalyst, this event highlights how traditional market stabilization can spill over to crypto via improved risk appetite.

Goldman Sachs strategist Timothy Moe predicts a rebound in South Korean stocks after a drop that triggered a circuit breaker.

Goldman Sachs' Korean Stock Rebound Call Could Squeeze Altcoin Liquidity

Goldman Sachs' bullish Korean stock call may drain liquidity from altcoins as retail traders shift capital to equities, amplifying the bearish divergence between Bitcoin and altcoins.